BIOREM Inc. BIRMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 32.32% | 22.55% | 11.51% | -15.79% | 21.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.32% | 22.55% | 11.51% | -15.79% | 21.38% |
| Cost of Revenue | 25.99% | 17.00% | 6.61% | -6.34% | 27.44% |
| Gross Profit | 49.53% | 38.36% | 24.79% | -35.93% | 7.47% |
| SG&A Expenses | 21.32% | 16.47% | 7.45% | -8.75% | 25.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00% | 100.00% | 100.00% | -1,616.67% | -- |
| Total Operating Expenses | 25.73% | 17.28% | 7.10% | -7.02% | 26.68% |
| Operating Income | 80.66% | 64.36% | 43.61% | -56.66% | -7.13% |
| Income Before Tax | 89.93% | 72.86% | 49.89% | -58.90% | -7.81% |
| Income Tax Expenses | 74.70% | 55.55% | 34.83% | -55.41% | 3.80% |
| Earnings from Continuing Operations | 95.46% | 79.16% | 55.35% | -60.05% | -11.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.46% | 79.16% | 55.35% | -60.05% | -11.41% |
| EBIT | 80.66% | 64.36% | 43.61% | -56.66% | -7.13% |
| EBITDA | 71.07% | 56.79% | 40.98% | -52.82% | -1.28% |
| EPS Basic | 99.52% | 84.40% | 59.96% | -60.59% | -12.04% |
| Normalized Basic EPS | 93.51% | 77.54% | 54.06% | -59.48% | -8.46% |
| EPS Diluted | 109.85% | 96.48% | 69.69% | -62.26% | -17.26% |
| Normalized Diluted EPS | 99.24% | 84.17% | 59.43% | -60.71% | -14.66% |
| Average Basic Shares Outstanding | -0.64% | -0.40% | 0.40% | 1.48% | 1.32% |
| Average Diluted Shares Outstanding | -3.07% | -3.23% | -2.24% | 3.59% | 5.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |